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Background: Characterization of allergic responses to cockroach (CR), a common
aeroallergen associated with asthma, has focused mainly on IgE reactivity, but little
is known about T cell responses, particularly in children. We conducted a functional
evaluation of CR allergen‐specific T cell reactivity in a cohort of CR allergic children
with asthma.
Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 71
children, with mild‐to‐moderate asthma who were enrolled in a CR immunotherapy
(IT) clinical trial, prior to treatment initiation. PBMC were stimulated with peptide
pools derived from 11 CR allergens, and CD4+ T cell responses assessed by intra-
cellular cytokine staining.
Results: Highly heterogeneous responses in T cell reactivity were observed among
participants, both in terms of the magnitude of cytokine response and allergen
immunodominance. Reactivity against Bla g 9 and Bla g 5 was most frequent. The
phenotype of the T cell response was dominated by IL‐4 production and a Th2
polarized profile in 54.9% of participants, but IFNγ production and Th1 polarization
was observed in 25.3% of the participants. The numbers of regulatory CD4+ T cells
were also highly variable and the magnitude of effector responses and Th2 polari-
zation were positively correlated with serum IgE levels specific to a clinical CR
extract.
Conclusions: Our results demonstrate that in children with mild‐to‐moderate
asthma, CR‐specific T cell responses display a wide range of magnitude, allergen
dominance, and polarization. These results will enable examination of whether any
of the variables measured are affected by IT and/or are predictive of clinical
outcomes.
K E YWORD S
allergens, asthma, clinical immunology, cockroach, T cell
1 | INTRODUCTION
Cockroach is a common allergen in urban and under‐resourced areas
and a significant source of atopic morbidity worldwide, particularly
among children and young adults.1‐3 The German cockroach (CR,
Blattella germanica) is commonly associated with CR allergies in the
United States with CR allergens being detected in 85% of homes in
low‐income urban communities.4 CR allergy has a high prevalence,
and has long been established as a strong cause of asthma initiation
and progression with early exposure leading to increased CR sensi-
tization, asthma severity, and morbidity.4‐8
Several studies defined CR allergens based on IgE reactivity from
sensitized individuals and correlated sensitization prevalence with
severity of clinical symptoms.3,9‐12 T cells, and in particular type 2T
helper cells, significantly contribute to the development of allergy
and asthma13‐15; however, CR‐specific T cell responses have been
characterized in less detail,16‐21 and very little information is avail-
able particularly for the population most impacted by CR allergies,
namely urban and under‐resourced children.
In general, allergen‐specific T cell responses are often charac-
terized following in vitro expansion steps17,22‐25 to account for their
low frequency which may also alter the phenotype of responding T
cells.26 We and others previously demonstrated that allergen‐specific
T cells can be detected ex vivo using a novel assay strategy with the
combination of several T cell epitopes into pools.24,27‐29 This tech-
nique uses the upregulation of the activation markers such as CD154
(CD40L) as a read‐out for T cell reactivity and can be combined with
intracellular cytokine staining (ICS) to further identify T cell pheno-
types as well as polyfunctionality24,27,30 and to improve the charac-
terization of CR‐specific T cell responses.
Thirteen groups of German CR allergens have been defined
based on IgE reactivity and are listed at the official allergen database
maintained by the World Health Organization and International
Union of Immunological Societies (WHO/IUIS) Allergen Nomencla-
ture Sub‐committee (www.allergen.org).2 As in the case of other al-
lergies (i.e., cat, mite, or mouse24,27,31,32), certain allergens have been
described as dominant for CR‐specific T cell responses. Those studies
however were associated with certain limitations, such as testing a
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set of candidates derived from predicted epitopes from a more
limited set of allergens, reliance on in vitro expansion and re‐
stimulation steps, and most importantly they only addressed
dominance in sensitized adults.16‐18
Here we characterized the patterns of T cell responses to 11
cockroach allergens in a cohort of children with CR sensitization and
asthma with a median age of 12 years that were enrolled as potential
participants in an IT clinical trial (CRITICAL) and before initiation of
treatment. T cell responses for each individual allergen were
assessed by conducting ex vivo assays directly from PBMC not pre‐
stimulated with CR extract using pools of overlapping peptides
spanning the entire protein sequence of the various CR allergens. The
basal numbers of regulatory CD4+ T cells (Tregs) was also assessed,
and compared with the magnitude of effector T cell responses.
Additional correlation analyses were performed to examine the
relationship of T cell responses to skin prick test and serological IgE
responses33 as well as to the Composite Asthma Severity Index
(CASI) and its components.34
2 | METHODS
2.1 | Study subjects
This cohort is part of an ongoing clinical trial CRITICAL (Cockroach
Immunotherapy in Children and Adolescents; https://clinicaltrials.
gov/ct2/show/NCT03541187). Subjects were enrolled if they were
IgE sensitized to CR antigen (measured by skin prick testing and
serum IgE) and were ages 8 through 17 with well‐controlled asthma
(mild‐moderate persistent) at study entry (Table 1). Clinical charac-
teristics and evaluation are detailed in the online supporting infor-
mation. The study was approved via a central Institutional Review
Board, the Western IRB (WIRB Tracking Number 20180698), the
DAIT NIAID and NIH/IND# 17979 (Protocol ID#: ICAC‐28). All
participants enrolled in this study provided written consent or
provided assent with parental consent.
2.2 | PBMC isolation
Peripheral blood mononuclear cells (PBMC) were isolated from
whole blood by using CPT (cell preparation tubes) tubes according to
the manufacturer's instructions (BD Vacutainer CPT tube with
sodium heparin BD 362753, BD Biosciences) as detailed in the online
supporting information.
2.3 | Measurement of IgE, IgG, and IgG4 antibody
and peptide synthesis
Cockroach‐specific IgE, IgG, and IgG4 antibody levels were measured
in sera using a Thermo Fisher Scientific ImmunoCAP system (Phadia
250 Immunoassay Analyzer; Thermo Fisher Scientific) as explained in
the online supporting information. Sequences of 11 major cockroach
allergens were collected from UniProt. A strategy using 15mer
peptides overlapping by 10 amino acids was selected to get the full
coverage of all the allergens (Table S1). It is well established that
epitopes bind to HLA‐class II molecules through a nine residues core,
and are on average 14–16 residues in overall length. The peptide
selection utilized in this manuscript and commonly utilized in other
studies relies on the fact that ensures that each 9 “core” amino acids
that bind to the MHC‐II groove is contained in at least one peptide.
An alternative strategy would be to generate 15mers overlapping by
14 amino acids. Although more rigorous, this strategy would signifi-
cantly increase the number of peptides to be generated and tested
which was not feasible in light of the limited numbers of cells avail-
able to study. Peptides were purchased from A & A as crude material
on a small (1 mg) scale.
2.4 | Activation Induced Marker (AIM) assay and
experimental design
Evaluations of T cell responses were based on previously described
Activation Induced Marker (AIM) ex vivo assays,30,35,36 utilizing the
CD154 (CD40L) and CD137 (4‐1BB) markers, combined with intra-
cellular cytokine staining (ICS), using the antibodies described in
Table S2 and performed as detailed in the online supporting infor-
mation. The cytokines IL‐4, IFNγ, and IL‐10 were included as repre-
sentative of Th2, Th1, and Tr1/T Regulatory (Tregs) CD4 helper T cell
subsets, respectively.24,37 The phenotypic CD127 and CD25 Tregs
markers were also included in the cytometry analysis panel30,38 and
the several T cell parameters determined as described in the
supporting information.
2.5 | Statistical analysis
Comparisons between cytokine responses were performed using the
nonparametric two‐tailed, paired Wilcoxon test. Correlations be-
tween magnitude of response and polarization or between different
cytokine production in each participant were performed using the
Spearman's rank correlation coefficient test. No adjustment for
multiple comparisons was performed. Pearson correlation test was
used to compare the two different measurements of Tregs. Prism
8.0.1 (GraphPad) was used for these calculations. Values pertaining
to significance and correlation coefficient (R) are noted in the
respective figure, and P < 0.05 defined as statistically significant.
3 | RESULTS
3.1 | Study strategy
PBMC were obtained from 71 study participants enrolled from 11
clinical sites prior to allergen IT and cryopreserved for subsequent
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analysis (Figure 1a). To characterize the magnitude and polarization
of allergen responses directed against Blatella germanica (Bla g)
allergens, we tested sets of overlapping peptides, spanning the entire
sequence of 11 different CR allergens, using Activation Induced
Marker (AIM) assays,30,35,36 combined with Intracellular Cytokine
Staining (ICS; Figure 1b and see supporting information for more
detail).
Figure 1c shows representative data for the detection of each
cytokine. Three different donors where used for the different cyto-
kine measurements. Specifically, IL‐4 response to Bla g 9, IFNγ
response to Bla g 3, and IL‐10 response to Bla g 2 allergen peptide
pool stimulation. Strong cytokine production was observed in
response to the positive control (PMA/Ion) but not in response to the
negative control (DMSO) or peptide pools from allergens not
recognized for a particular donor. For each participant, individual IL‐
4, IFNγ, and IL‐10 cytokine responses to each pool was summated to
determine the total number of effector T cells (Teff; antigen‐specific
CD154+ cells24,30).
3.2 | Overall magnitude and polarization of Bla
g‐specific T cell responses
The overall magnitude of CD4+ T cell CR‐specific responses is
shown in Figure 2a, where for each participant a bar represents the
total cytokine response for all the different allergens combined.
Each bar is further color coded to show which fraction of the
response for each participant is accounted for IL‐4 (blue), IFNγ
(red), or IL‐10 (green). The overall magnitude of baseline responses
varied over approximately 2 logs across different subjects in the
study cohort (ranging from 21 to 1198 cells per million of CD4+ T
cells).
This large variation between participants was not the result of
assay‐to‐assay variability, as demonstrated by specific controls uti-
lized in the assays. More specifically, in each assay, we also included a
PBMC aliquot from an adult volunteer with a moderate degree of
cockroach allergy, who underwent apheresis to provide numerous
cell aliquots available for use. As shown in Figure S1a, limited assay‐
to‐assay variability was observed in repeated assays (n = 42) from
the lowest to the highest response in the 3.3‐fold range, which is far
less variable than variability observed within the participant cohort
(57‐fold). Furthermore, as shown in Figure S1b, the variation in the
percent of each cytokine for the control donor was calculated for
each repeated assay. The response accounted predominantly for IL‐4
cytokine secretion and, the Th2 polarization (>50% of total response)
was consistently observed in all technical repeats (n = 42). Lastly, no
significant difference was observed in the magnitude of response as a
function of the different clinical sites from which the subjects were
enrolled (Figure S1c).
Overall, IL‐4 responses across the different participants were
significantly larger than the IFNγ and IL‐10 responses, approxi-
mately 2‐fold and 4‐fold larger, respectively (Figure 2b). This was
expected as all subjects in the study cohort were diagnosed with
allergic asthma, and that a Th2 profile is a characteristic feature of
allergic responses.39,40 To visualize the nature and degree of po-
larization as a function of each individual participant, the same data
were plotted in an alternative format (Figure 2c) where, for each
participant, the percent of the total response to be ascribed to each
of the three cytokines was plotted and grouped according with their
polarization profile (>50% of total response). The responses in most
participants (n = 39/71) were IL‐4 polarized (i.e., IL‐4 is the domi-
nant cytokine produced), while only 18 and 3 participants were
IFNγ and IL‐10 polarized, respectively. No clear polarization was
noted for an additional 11 participants. Interestingly, an IFNγ and
IL‐4 co‐dominant pattern was observed in 4 out of those 11
individuals.
The data in Figure 2a indicate that the most vigorous responses
were also the most polarized toward IL‐4 production. Further analysis
(Figure 2d) found that the total magnitude (total cytokine response)
correlated with Th2 (IL‐4) responses (p < 0.0001; R = 0.59) and
inversely correlated with Th1 (IFNγ) and IL‐10 producing cells
(p = 0.0009; R = −0.38 and p < 0.0001; R = −0.53, respectively).
These results suggest that stronger responses to CR allergens were
more IL‐4 polarized, and that weaker responses were associated with
IFNγ and/or IL‐10 production. Correlation between the different
cytokine responses in each individual participant was also analyzed.
As shown in 2, IFNγ and IL‐10 responses were highly correlated but
IL‐4 did not correlate with IFNγ or IL‐10 responses. Further corre-
lation analysis comparing the polyclonal T cell responses (PMA/Ion
stimulation) and CR‐specific T cell responses was performed. As
shown in Figure S3, CR‐specific immune responses in this study do not
reflect the general immune responses at the individual donor level.
TAB L E 1 Characteristics of the donor cohort
Participating













Black or African American (63.4) White
(18.3) Other (18.3)
Range 8–17 2–8 0.12–>100 3.0–17.5
Median 12.0 4.0 2.8 6.0
Average 12.0 3.7 23.5 6.9
Std deviation 2.4 1.3 69.6 3.3
aCASI stands for Composite Asthma Severity Index. Range of scores: 0 (least severe) to 20 (most severe) asthma.
bSPT stands for skin prick test.
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Lastly, in these experiments, we also included a previously
described megapool of Bordetella pertussis (BP) epitopes.41 Children in
our cohort, based on their year of birth, are expected to have been
vaccinated with the acellular pertussis (aP) vaccine which is associ-
ated with a predominantly Th2 response.42,43 As expected, and
shown in Figure S4a, BP responses in this cohort were Th2 polarized,
with a median ratio of IL‐4/IFNγ cytokine response of 2.5 and
significant participant‐to‐participant variability. The degree of Th2
polarization observed in the BP responses did not correlate with the
degree of polarization observed in the CR responses (Figure S4b),
suggesting that there are factors determining the degree of Th2
polarization that are antigen/allergen‐specific.
3.3 | Bla g 9 and Bla g 5 are the most dominant
allergens for T cell responses
Previous studies established that certain allergens are immunodo-
minant (i.e., account for a larger fraction of the total response)17,24,44
at the population level. However, more granular analyses also
F I GUR E 1 Study design and experimental strategy. (A) A total of n = 71 subjects were enrolled from 11 clinical sites, and blood samples
were collected and PBMC isolated and cryopreserved. (B) PBMC were tested against a set of peptide pools consisting of overlapping peptides
spanning the entire sequence of 11 different CR allergens, and T cell cytokine responses assessed by a combination of the Activation Induced
Marker (AIM) and Intracellular Cytokine Staining (ICS) assays after 6 h of stimulation. (C) Dot plots depict the cytokine detection of IL‐4, IFNγ,
and IL‐10 in CD154+ CD4+ T cells after stimulation with DMSO, PMA/Ion or sets of peptide pools for a given allergen. Three different donors
are shown to illustrate the measurements of IL‐4, IFNγ, and IL‐10 cytokine secretion to a particular high‐reactive CR allergen and the absence
of response to a particular CR allergen as control. Specific allergen tested in each condition is indicated in dot‐plots as well as the frequency of
CD154+ cytokine + events of total CD4+ T cells
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established that individual patterns of immunodominance are also
detected, and the immunodominant antigens can vary from one in-
dividual to the next.10,11,16
Accordingly, we first established which specific CR allergens
would be dominant for T cell responses in the cohort of allergic
CR‐sensitized children. Figure 3a shows the overall response
directed against each allergen, calculated by summing, separately for
each individual allergen, the responses observed in each individual
participant. The Bla g 9 and Bla g 5 allergens were the most domi-
nant, accounting for 38.8% and 11.1% of the total response. Other
allergens were also recognized, albeit to a lower extent. When
considering the individual types of immune responses Bla g 9 was by
large the most dominant allergen of IL‐4 responses (52.1%), and Bla g
3 (16.0%) or Bla g 2 (14.5%) the most dominant allergens of IFNγ and
IL‐10 cytokine responses, respectively (Figure 3a and Figure S5).
Next, the data were analyzed at a higher level of granularity to
investigate which antigens would be more dominantly recognized for
each of the subjects tested, and each participant was assigned to
different immunodominance categories. In terms of total cytokine
response (Figure 3b), a total of 19 participants recognized the Bla g 9
allergen as most dominant, while Bla g 5 was most dominant in 7
participants. Bla g 3 and Bla g 7 were dominant in 4 participants, and
F I GUR E 2 Baseline cytokine responses of CD154+ cells are IL‐4 polarized and correlate with magnitude of responses. (A) Graph bars
show the overall magnitude of CD4+ T cell CR‐specific responses as the sum of the 11 individual allergens tested. Each bar represents a
participant (n = 71) and the fraction of the response accounted for each cytokine (IL‐4 (blue), IFNγ (red), or IL‐10 (green)). (B) Graph compares
the IL‐4, IFNγ and IL‐10 allergen responses for all the individual participants combined. Geometric mean and p value are shown as statistically
significant by Wilcoxon's paired t‐test. (C) Graphs depict the percentage of each individual cytokine contribution from total response, grouped
as function of the IL‐4, IFNγ, IL‐10 dominant (>50% of total response) or non‐dominant cytokine profile for a particular participant. Each dot
and interconnected lines represents a participant and the number of participants in each group is shown. (D) Graphs show the correlation of
total cytokine response with the relative IL‐4, IFNγ and IL‐10 cytokine response. R values and p values are shown as statistically significant by
nonparametric Spearman correlation test and best fit represented by a linear regression line (red)
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Bla g six in 3 participants. The other allergens were dominant in one
and two participants each or none, and patterns of co‐dominance or
no clear pattern of dominance were detected for 28 participants
(Figure 3b).
3.4 | Detection of basal levels of regulatory T cells
In the next series of experiments, we analyzed the number of Tregs at
baseline in the absence of antigen stimulation. We defined baseline
Tregs as the total number of CD137 + CD154‐ T cells detected at
baseline,without anyantigen stimulation.30Asexpected, Tregs defined
as CD137+ were correlated with Tregs defined by the alternative
markers CD4+CD25 + CD127low38,45 (Figure 4a and 4b). There was
substantial variation in the number of Tregs (total CD137+) among
participants (Figure 4c), the number of CD137+ cells varing 90‐fold
from 925 to 86,000 per million CD4+ T cells.
We hypothesized that the size of the baseline Treg population
present in each individual might influence their capacity to mount an
allergen‐specific T cell response following stimulation with the
allergen‐derived peptide pools. There was a suggestion of an inverse
correlation between the number of Tregs (CD137+ unstimulated
cells) and the number of Teff (cytokine + CD154+ allergen‐
stimulated cells), but this was not statistically significant
(Figure 4d). We further observed to be the case in patients with IL‐4
but not IFNγ dominant responses (Figure S6).
F I GUR E 3 Bla g 9 and Bla g 5 are the most immunodominant allergens and dominance is participant specific. (A) Graph shows the overall
response directed against the 11 allergens tested, calculated by summing each individual allergen response for all participants. Each bar
represents an allergen and the fraction of the response accounted for each cytokine (IL‐4 [blue], IFNγ [red], or IL‐10 [green]). Table depicts the
percentage of total or individual cytokine responses for each allergen. (B) Graphs show for each individual participant (dots and
interconnected lines) the fraction of the response accounted for each allergen and grouped as a function of allergen immunodominance (‐high)
or lack of dominance. Bla g 1 and Chitinase not shown in graphs as no dominant responses were observed. The number of participants
associated with each category is shown
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3.5 | Correlation of T cell responses with sera
antibody titers to CR extract, SPT responses, and
clinical presentation
We also tested whether T cell responses were associated with IgE,
IgG, and IgG4 titers specific for CR as well as with the ratio between
IgE/IgG4 responses. The results summarizing these analyses
are shown in Table 2. A significant correlation was observed between
IL‐4 responses or IL‐4 (Th2) polarization and IgE levels (p = 0.0003;
R = 0.42 and p < 0.0001; R = 0.45, respectively) and to a less extent
with total IgG but not IgG4. Conversely, IFNγ (Th1) and IL‐10
polarization showed an inverse correlation with the IgE titers
(p = 0.0044; R = −0.33 and p = 0.0013; R = −0.37, respectively).
The same results were noted in regards to the correlation with the
IgE/IgG4 ratios. In addition, as shown in Table 2, the total magnitude
of responses positively correlated with IgE titers or the IgE/IgG4
ratios (p = 0.0082; R = 0.31 and p = 0.0071; R = 0.32, respectively),
and no associations were observed for Treg frequencies.
We next examined the correlation of T cell responses with the
results of a skin prick test (SPT) specific for extracts of German and
American CR, which share homologous allergens (www.allergen.org).
As shown in Table S3, total responses or IL‐4 responses were posi-
tively but weakly correlated (p = 0.035; R = 0.25 and p = 0.042;
R = 0.35, respectively), while IL‐10 polarization was negatively
correlated (p = 0.015; R = −0.29) with the mean wheal diameter
(MWD) of the SPT for the American CR extract. Conversely, none of
the T cell variables correlated with MWD of the SPT for the German
CR extract (Table S3). Despite differences in the source of the CR
F I GUR E 4 Treg numbers varies amongst participants and are inversely correlated with Teff responses. (A) Dot plots show a
representative participant for the Treg gating strategy. (B) Graph show the correlation of total CD137+ cells and CD25 + CD127low CD137+
cells in unstimulated cells by Pearson correlation test. (C) Graph bars show the number of Tregs (CD137+ cells) across all participants (n = 71).
Figure insert depicts 2 representative participants with High or Low Treg populations, respectively. (D) Graph shows the correlation of Tregs
(Total CD137+ unstimulated cells) and Teff (cytokine + CD154+ allergen‐stimulated) cells by nonparametric Spearman correlation test. For
both correlation graphics, each dot represents a participant (n = 71). R values and p values are shown and best fit represented by a linear
regression line (red)
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extract considered, these results confirm the associations noted at
the serological level.
Lastly, we examined correlations of the T cell variables (magni-
tude, polarization, or dominance of specific allergens) with clinical
variables such as those captured by Composite Asthma Severity In-
dex (CASI) score and components.34 As shown in Table S4, none of
the T cell immunological variables correlate with the total CASI score.
Also, no differences were observed in clinical symptoms between
patients with IL‐4 or IFNγ dominant responses (Figure S7). These
results were not unexpected given the fact that this cohort was
designed to encompass relatively homogeneous CASI scores, ranging
from low to medium severity (median CASI of 4).
4 | DISCUSSION
Here we report the direct ex vivo characterization of T cell responses
to a panel of 11 previously described CR allergens in a cohort of CR
allergic children and adolescents with well‐controlled asthma. In
particular, we found over 57‐fold variation in magnitude of allergen‐
specific T cell responses. The more vigorous responses were also the
most Th2 polarized and while the allergens Bla g 9 and Bla g 5 were
most immunodominant, individual subjects exhibited distinctive
patterns of allergen dominance. Subjects with higher magnitude of
allergen‐specific T cell reactivity had lower number of Treg
populations. Overall, this study unveils a surprisingly high level of
heterogeneity in the pattern of Bla g‐specific T cell reactivity, both
quantitatively and qualitatively. Since the cohort analyzed is enrolled
in a future IT clinical trial, this finding lays the foundation for
examining whether this heterogeneity may potentially correlate with
IT outcomes.
This study is to the best of our knowledge, the first character-
ization of ex vivo CR‐specific CD4+ T cell responses in CR‐sensitized
urban and under‐resourced children with asthma, and for the ma-
jority of the known CR allergens to date, which are also components
commonly found in CR extracts used for IT.2,10 Our results also differ
from previous attempts of portrayal of CR‐specific responses,17,19,20
because of the high level of granularity and because the ex vivo
TAB L E 2 Correlation of T cell
responses with cockroach (CR)‐extract
specific titers
Spearman r IgE Ext (RUa) IgG Ext (RUa) IgG4 Ext (RUa) Ratio IgE/IgG4
Total magnitude of responses (CD154)
R 0.31 0.15 0.14 0.32
P value 0.0082 0.2125 0.2542 0.0071
IL‐4 responses (CD154)
R 0.42 0.2 0.12 0.43
P value 0.0003 0.0965 0.3141 0.0002
IL‐4 (Th2) polarization
R 0.45 0.26 0.12 0.43
P value <0.0001 0.0301 0.3378 0.0002
IFNγ responses (CD154)
R −0.1 −0.13 0.07 −0.1
P value 0.3952 0.2704 0.5647 0.398
IFNγ (Th1) polarization
R −0.33 −0.26 −0.085 −0.33
P value 0.0044 0.0263 0.4784 0.0047
IL‐10 responses (CD154)
R −0.18 13 −0.00099 −0.2
P value 0.1328 0.2979 0.9935 0.096
IL‐10 polarization
R −0.37 −0.18 −0.099 −0.41
P value 0.0013 0.1347 0.411 0.0003
Treg baseline numbers
R −0.11 −0.15 −0.062 −0.093
P value 0.3729 0.2209 0.6047 0.4384
aRU stands for relative units.
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approach allowed to characterize responding cells to a minimal gap
from bona fide in vivo responses.
We identified a large dynamic range in terms of magnitude of
CD4+ T cell responses, despite the narrow age range and similar
clinical manifestations of disease among participants. Positive con-
trols included in each assay excluded that this was due to inter‐assay
variability. The assessment of the variation of PBMC from the same
subjects taken at different time points would have also been of great
interest but limited by the number of existing cells available to
perform the tests. Nevertheless, this should be considered in future
study designs. Likewise, the variability was not explained by differ-
ential responses as a function of the different clinical sites from
which each subject was enrolled. A high spread in the magnitude of T
cell responses has been previously described for other allergic re-
sponses, namely to cat dander, fungus, mite and grass or birch
pollen30,46,47 using ex vivo methodologies similar to our study. It is
possible that the ex vivo assay strategy utilized contributed to reveal
this heterogeneity, as previous allergy studies in the case of
CR16,18,20 or other allergens24,27 utilized in vitro restimulation
protocols which might obscure and blunt differences.
We also analyzed the functionality of CD4+ T cell responses,
which was dominated by IL‐4 production and a Th2 polarization
profile. Development of early allergic disease seems to be related to
sustained Th2‐skewed immunity during childhood48 and previous
studies have also demonstrated that levels of Th2 cytokines such as
IL‐4, IL‐5, and IL‐13 are associated with pathogenesis of both allergy
and asthma.13‐15 In our study, Th2 polarization was the dominant
phenotype but other patterns were also observed. The accuracy of
this characterization was confirmed with a positive control included
in each assay. In particular, while IL‐10 responses were rare, a profile
of IFNγ production or Th1 polarization was observed in one‐fourth of
the participants and associated with weaker T cell CR‐specific re-
sponses. Also, since IFNγ is thought to be secreted in higher amounts
per cell than IL‐4, perhaps the actual net amount of cytokine pro-
duction might not necessarily correlate with the number of cytokine
secreting cells as determined herein, but additional studies would be
needed to clarify this conjecture. Interestingly, resolution of allergic‐
related immunopathologies is often also attributed to increase of
IFNγ levels rather than reduction of Th2‐cytokine production,49 and
IL‐10 is found to regulate CD4+ Th2 cells during allergic airway
inflammation.50 Therefore, the close monitoring of both IL‐10 and
IFNγ cytokines would be of interest in the context of IT and could
provide new clues for the association of baseline patterns of polari-
zation or dominant allergens and IT outcomes.
Bla g 9 (arginine kinase) and Bla g 5 (glutathione‐S‐transferase)
were the most immunodominant allergens. Interestingly, these en-
zymes are well conserved among arthropods or insects and have
been shown to cross‐react with human IgE antibodies51,52 and are
often considered pan‐allergens and important players in the clinical
manifestation of allergic sensitization.53 Also, previous studies have
reported Bla g 5 as a dominant T cell allergen10,16,17 but patterns of
allergen dominance could be associated with different forms of
allergic disease.17 These observations were made in adult cohorts,
and this raises the possibility that Bla g 9 recognition could be a
pattern predominantly associated with childhood CR allergy.
This pattern of immunodominance has been observed in subjects
from the different clinical sites, irrespective of geographical location,
further suggesting that Bla g 5 and Bla g 9 responses to CR are
intrinsic to this particular age cohort. Changes in the IgE pattern of
reactivity to individual Timothy grass and birch pollen allergens were
observed over the course of 20 years for sensitized individuals.54
Future studies could examine whether changes in allergen immuno-
dominance are apparent as a function of age and exposure history.
The pattern of reactivity as a function of the specific subject
considered was also heterogeneous with different individuals
recognizing either Bla g 9 or Bla g 5 as dominant, with dominant
responses to other allergens or no pattern of dominance also
observed. Individual immunodominance patterns were observed in
adult cohorts16 and for IgE reactivity.55 Different HLA could influ-
ence allergen immunodominance. Associations between CR sensiti-
zation and HLA class II antigens have been suggested56,57 and
consistently shown in food allergies.58,59
In addition, we measured basal levels of non‐antigen specific
regulatory T cells and observed that T cells inversely correlated
with the effector CD4+ T cell responses although it did not reach
statistical significance. These results were not unexpected and were
consistent with previous observations from Bacher et al.30. The fact
that the population of Treg cells varies amongst participants is also
of potential interest, as this will enable monitoring of Treg and
addressing whether baseline Treg levels predicts response to IT. A
possible outcome is that IT may induce or enhance regulatory T cell
function, which can be further tested. Indeed, peanut oral immu-
notherapy has been shown to increase antigen‐induced Treg
function.60
Overall, the current study reveals that in a pediatric cohort of
CR‐sensitized subjects with mild‐to‐moderate asthma, subjects
exhibit substantial heterogeneity in many key immunological pa-
rameters associated with CR‐specific T cell responses. We hypothe-
size that this large dynamic range of T cell reactivity may influence
outcomes of allergen‐specific IT. These findings will also enable
future research examining which of these parameters best predict
the trajectory of evolution of allergic disease, and responsiveness to
therapeutic intervention.
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